NovoCure Limited (NVCR)
NASDAQ: NVCR · Real-Time Price · USD
18.00
+0.90 (5.26%)
At close: Jun 27, 2025, 4:00 PM
17.96
-0.04 (-0.22%)
After-hours: Jun 27, 2025, 5:20 PM EDT
NovoCure Employees
NovoCure had 1,488 employees as of December 31, 2024. The number of employees increased by 35 or 2.41% compared to the previous year.
Employees
1,488
Change (1Y)
35
Growth (1Y)
2.41%
Revenue / Employee
$417,817
Profits / Employee
-$110,340
Market Cap
2.01B
Employees Chart
Employees History
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
NVCR News
- 26 days ago - NovoCure's Tumor Treating Fields Boost One-Year And Pain-Free Survival In Pancreatic Cancer Trial - Benzinga
- 4 weeks ago - Zai Lab and Novocure Announce Results From the Phase 3 PANOVA-3 Trial of Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting - Business Wire
- 4 weeks ago - Results From the Phase 3 PANOVA-3 Trial of Novocure's Tumor Treating Fields (TTFields) Therapy for Pancreatic Cancer to be Presented at 2025 ASCO Annual Meeting - Business Wire
- 4 weeks ago - Novocure Announces Upcoming Investor Events - Business Wire
- 5 weeks ago - NovoCure: Loading Up On Growth Catalysts - Seeking Alpha
- 2 months ago - NovoCure Warns Of Potential $11 Million Tariff Hit If US Trade Pause Expires In 2025 - Benzinga
- 2 months ago - NovoCure Limited (NVCR) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Novocure Reports First Quarter 2025 Financial Results - Business Wire